19-7689243-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001220500.2(FCER2):c.916C>T(p.Pro306Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000178 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001220500.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FCER2 | NM_001220500.2 | c.916C>T | p.Pro306Ser | missense_variant | 11/11 | ENST00000597921.6 | |
FCER2 | NM_002002.5 | c.916C>T | p.Pro306Ser | missense_variant | 11/11 | ||
FCER2 | NM_001207019.3 | c.913C>T | p.Pro305Ser | missense_variant | 10/10 | ||
FCER2 | XM_005272462.5 | c.916C>T | p.Pro306Ser | missense_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FCER2 | ENST00000597921.6 | c.916C>T | p.Pro306Ser | missense_variant | 11/11 | 1 | NM_001220500.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152186Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000845 AC: 21AN: 248520Hom.: 0 AF XY: 0.000104 AC XY: 14AN XY: 134652
GnomAD4 exome AF: 0.000184 AC: 269AN: 1461520Hom.: 0 Cov.: 31 AF XY: 0.000172 AC XY: 125AN XY: 727054
GnomAD4 genome AF: 0.000118 AC: 18AN: 152186Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74338
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 24, 2022 | The c.916C>T (p.P306S) alteration is located in exon 11 (coding exon 10) of the FCER2 gene. This alteration results from a C to T substitution at nucleotide position 916, causing the proline (P) at amino acid position 306 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at